×
0 -0.00746268656716418 0 -0.00895522388059693 -0.0298507462686567 -0.0388059701492536 -0.0447761194029851 -0.0462686567164178
Stockreport

Momenta Pharma hits volatility circuit breaker on reports that it may explore strategic options; shares up 11% [Seeking Alpha]

MOMENTA PHARMACEUTICALS (MNTA)  More Company Research Source: Seeking Alpha
Last momenta pharmaceuticals earnings: 2/21 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.momentapharma.com/investor-relations
PDF Momenta Pharma hits volatility circuit breaker on reports that it may explore strategic options; shares up 11%Nasdaq temporarily suspended trading in Momenta Pharmaceuticals (MNTA+10.6%) due to volatility. Shares spiked onreports that it may explore strategic alternatives.The company has two products on the market:Glatopa (glatiramer acetate injection), a generic version of Teva's MS med Copaxone andEnoxaparin Sodium Injection, a generic version of Sanofi's deep vein thrombosis med Lovenox.See all stocks on the move »Now read:Sector Report: How The Pressure On Generic Drugs Is Creating Tailwind For Branded Molecules » [Read more]

IMPACT SNAPSHOT EVENT TIME: MNTA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS